This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Feb. 7, 2012 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio"), a leading
China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that Dr.
Jing Lou, chief executive officer, and Mr.
Bo Tan, chief financial officer, will present at the Oppenheimer & Co. 6th Annual China Dragon Conference being held
March 14-15, 2012 in
New York City.
The accompanying slides will be available at
www.3sbio.com under the investor relations section.
About 3SBio Inc.
3SBio is a leading, fully integrated, profitable biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in
China. Its focus is on addressing large markets with significant unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases. With headquarters and GMP-certified manufacturing facilities in
Shenyang, PRC, 3SBio employs over 800 people. Shares trade in the form of American Depositary Shares (ADSs) on the NASDAQ stock market under the ticker symbol "SSRX". Please see
www.3SBio.com for more information.
Investor ContactsBo TanChief Financial Officer3SBio Inc.Tel: + 86 24 2581-1820
ir@3SBio.comTom FolinsbeeDirector of Investor Relations3SBio Inc. Tel: + 852 8191-6991
SOURCE 3SBio Inc.